Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS application figures show a good upward trend
2008-10-23

Applications for admission to the University of the Free State (UFS) are showing an upward trend. In comparison with the same time last year, the total application figure has increased from 6 273 to 7 507 – a growth of 19,7%.

So far, applications for postgraduate studies are showing the biggest growth with 1 342 applications received. During the same time last year, 594 applications for postgraduate studies were received – an increase of 126%.

Prospective students have until 30 November 2008 to apply for admission. “This applies to first-time entering first-year students and senior students who have interrupted their studies for at least one year,” said Mr Vernon Collett, Registrar: Student Academic Services, at the UFS.

According to Mr Collett students whose applications for admission are received after 30 November 2008 and until 13 January 2009 will be accepted subject to the availability of place on the programme they applied for.

Applications from prospective students who wrote the Senior Certificate (prior to 2008) and who are in the possession of a conditional exemption will only be accepted until 5 January 2009.

Prospective students who want to apply must pay a non-refundable fee of R140.
The signed application form must be accompanied by a certified copy of the prospective student’s identity document or passport, a proof of payment of the application fee as well as a certified copy of their Statement of Results of their Senior Certificate.

Prospective students who are in Grade 12 this year will receive a National Senior Certificate. A certified copy of their Statement of Results must be faxed to the UFS not later than 7 January 2009.

The application form of a minor must be signed by his/her parent or guardian and the field of study should be clearly indicated.

First-time entering first-year students from the Faculties of Economic and Management Sciences and the Humanities (including Education) will be welcomed by the Acting Rector, Prof. Teuns Verschoor, on Friday, 9 January 2009 at 09:00 in the Callie Human Centre on the Main Campus.

The welcoming of students from the Faculties of Health Sciences, Natural and Agricultural Sciences, Law and Theology will take place on Saturday, 10 January 2009 at 09:00 in the Callie Human Centre.

The registration of first-time entering first-year students will commence on 13 January 2009 and that of senior students on 19 January 2009 at the Callie Human Centre according to a programme.

Students who applied for admission after 30 November 2008 and are accepted can register from 4 February 2009.

Lectures will commence on 2 February 2009 and the registration process will end on 10 February 2009. This is applicable to all students – undergraduate as well as postgraduates

Prospective students who want to apply for admission or who have any enquiries can call 051 401 3000 or visit the UFS web site at www.ufs.ac.za.

 
Media Release:
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
22 October 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept